Candidiasis, Esophageal: Clinical Trials

8 completed. 5 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

Phase	Trials	Status
Not applicable	5	Completed 5
Phase 2	1	Completed 1
Phase 3	1	Completed 1

Follow Candidiasis, Esophageal: new trials by email Literature Review of Candidiasis, Esophageal trials Research Report on Candidiasis, Esophageal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre CD4 cell count - HIV Infections, Tuberculosis		Completed	Singh, Ranjan Kumar, M.D.	257	2019-06-01	2020-03-19
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) Caspofungin - Candidiasis, Esophageal, Candidiasis, Invasive	Phase 2	Completed	Merck Sharp & Dohme LLC	20	2010-07-06	2018-08-27
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems Ketoconazole, Fluconazole - Candidiasis, Esophageal, HIV Infections	Not applicable	Completed	Pfizer			2005-06-24
Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients Amphotericin B - Candidiasis, Esophageal, HIV Infections	Not applicable	Completed	Bristol-Myers Squibb			2007-10-02
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women Fluconazole - Candidiasis, Candidiasis, Esophageal	Not applicable	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	400		2021-11-03
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems Fluconazole - Candidiasis, Esophageal, HIV Infections	Phase 3	Completed	Pfizer	100		2005-06-24
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis L-743,872 - Candidiasis, Esophageal, HIV Infections	Not applicable	Completed	Merck Sharp & Dohme LLC	18		2005-06-24
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. Itraconazole, Fluconazole - Candidiasis, Esophageal, HIV Infections	Not applicable	Completed	Janssen Pharmaceuticals			2005-06-24

Narrower conditions

Candidiasis (8)  ·  HIV Infections (7)  ·  Acquired Immunodeficiency Syndrome (5)  ·  Esophagitis (3)  ·  AIDS-Related Opportunistic Infections (2)  ·  Candidiasis, Oral (2)  ·  AIDS-Related Complex (1)  ·  Aspergillosis (1)  ·  Candidiasis, Invasive (1)  ·  Cryptococcosis (1)  ·  Esophageal Diseases (1)  ·  Leishmaniasis (1)  ·  Opportunistic Infections (1)  ·  Toxoplasmosis (1)  ·  Tuberculosis (1)

Broader conditions

Bacterial Infections and Mycoses (8)  ·  Infections (8)  ·  Mycoses (8)  ·  Blood-Borne Infections (7)  ·  Communicable Diseases (7)  ·  Genital Diseases (7)  ·  Immune System Diseases (7)  ·  Immunologic Deficiency Syndromes (7)  ·  Lentivirus Infections (7)  ·  RNA Virus Infections (7)  ·  Retroviridae Infections (7)  ·  Sexually Transmitted Diseases (7)  ·  Sexually Transmitted Diseases, Viral (7)  ·  Urogenital Diseases (7)  ·  Virus Diseases (7)

Interventions

Fluconazole (4)  ·  Caspofungin (2)  ·  Amphotericin B (1)  ·  CD4 Lymphocyte Count (1)  ·  Itraconazole (1)  ·  Ketoconazole (1)

Sponsors

Merck Sharp & Dohme LLC (2)  ·  Pfizer (2)  ·  Bristol-Myers Squibb (1)  ·  Janssen Pharmaceuticals (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Singh, Ranjan Kumar, M.D. (1)

Countries

United States (6)  ·  Canada (1)  ·  India (1)

Top investigators

L Capps (1)  ·  P Schuman (1)  ·  Ranjan K Singh, M.D. (1)

Results publications

PMID 25701307